Vaniqa

Eflornithine (α-difluoromethylornithine or DFMO) is a drug manufactured by Sanofi-Aventis which has various uses. It was initially developed for cancer treatment, but while having little use in treating malignancies, it was found to be highly effective in African trypanosomiasis (sleeping sickness), especially the West African form (Trypanosoma brucei gambiense). In the United States it is known by the brand name Ornidyl®.
See more at Wikipedia.org...

Eflornithine /ef·lor·ni·thine/ an inhibitor of the enzyme catalyzing the decarboxylation of ornithine ; used topically as the hydrochloride salt to [more]Vaniqa - Community and Resources